Tech Session I: Nanomedicine and Nanoscale Delivery (Focus: Immuno)

Tuesday, July 15, 2025

10:00 AM - 12:00 PM EDT

Location: 120 B/C

Chair(s)

Lisa Volpatti, PhD

Assistant Professor
Northwestern University, United States

Co-Chair(s)

Mansoor Amiji, PhD

University Distinguished Professor
Northeastern University
Boston, Massachusetts, United States

Development, physicochemical and biological characterization, in vivo validation, delivery of therapeutics, functionalization with active-targeting moieties, long-acting formulations, controlled release, injectables, implantables. (Focus: Immuno)

Presentations:

10:04 AM - 10:29 AM EDT

Subcutaneous administration of antibody-drug-conjugates
Invited Speaker - Exceptional Abstract: Alexandre Detappe, PhD (he/him/his) – Institut de Cancérologie Strasbourg Europe
10:29 AM - 10:54 AM EDT

Engineering Neutrophil-Targeted Antibiotic Nanoparticles to Prevent Lung Injury in Sepsis
Oral Abstract Speaker: Jacob W. Myerson, PhD – University of Pennsylvania
11:05 AM - 11:16 AM EDT

Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy in Multiple Myeloma
Oral Abstract Speaker: Shannuo Li – University of Utah
11:16 AM - 11:27 AM EDT

Triazine lipids as a platform for subunit vaccine development
Oral Abstract Speaker: Kaysi M. Lee, B.S. (she/her/hers) – Univerisity of Kentucky - College of Pharmacy
11:38 AM - 11:49 AM EDT

Understanding the inflammatory targeting of Lipid nanoparticles to deliver therapeutic RNAs
Oral Abstract Speaker: Riccardo Rampado, PhD (he/him/his) – University of Padova
11:49 AM - 12:00 PM EDT

Localized antitumor therapy via mitochondrial apoptosis with siRNA-loaded metallo-alginate hydrogels
Oral Abstract Speaker: jennifer fernández Alarcón, PhD – Institut Químic de Sarrià - Universitat Ramon Llull